Visions of 2020

This last week was actually a very good week for the Tailwinds' portfolio. Despite the overall quiet of a holiday week (or maybe because...

Bioasis Completes Bridge Financing Transaction

Tailwinds' Take: needed financing to keep things going until they can land a strategic investor. The clock is ticking on my ability to hold...

Several Thoughts On Micro-Cap Stocks I Follow

The market seems took a little hit this week, then bounced back. The net result of which was the wind coming out of the...

Bioasis Appoints Consultant Chief Medical Officer and Nominates Medical Oncology Advisory Board

Tailwinds' Take: the science behind XB3™ appears to be very interesting to the medical community. Hopefully this translates into some strategic partnerships soon. GUILFORD, Conn.–(Business...

Deep Fried Turkey

Those who know me well are well aware that Wednesdays are my favorite night of the week. That's the night I go out mountain...

Bioasis Announces Issuance of Japanese Patent Relating to xB3™ Platform Technology for The Delivery...

GUILFORD, Conn.–(Business Wire)– Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3™ platform technology for the...

Bioasis Announces Quarterly Results; Our Take

On Friday, my favorite little boom or bust biotech, Bioasis, reported their results. There is very little to learn from looking at the numbers;...

Bioasis Announces Proposed Private Placement

GUILFORD, Conn.–(Business Wire)– Bioasis Technologies, Inc . (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the delivery of therapeutics across...

Bioasis Announces Allowance of Patent Application in Japan Relating to xB3 Platform Technology for...

Tailwinds' Take: Nice to see this patent as it shows they continue to make progress behind the scenes, despite their noticeable lack of marketing...

Fall Investor Preview Along With A Belated August Recap

I’ve held off on my August recap much like a war veteran will refrain from telling tales from the trenches. Not that my experiences...

Bioasis Announces Registration and Grant Notice of Patent Application in China Relating to xB3...

GUILFORD, Conn.–(Business Wire)– Bioasis Technologies, Inc . (OTCQB:BIOAF; TSX.V:BTI), (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the...

Bioasis Engages With The FDA…Here’s What It Means

This week Bioasis heard back from the FDA on written questions they had submitted. These questions concern their lead investigational candidate xB3-001 and its...

Bioasis Announces FDA Response to Pre-IND Submission

Tailwinds' Take: Positive in that the timeline for development appears to be unchanged post the meeting, so that implies there were no significant issues...

Bioasis Announces Allowances of Patent Applications in the U.S. and Europe Relating to xB3...

Tailwinds' Take: this is a nice announcement, securing more IP around this platform technology. We remain intrigued by the Company, especially at this valuation,...

Markets Trade Down In May…June Preview

I'm not sure why, but it seems that every time I feel the Tailwinds' Portfolio is poised for big gains, the market enters a...

Bioasis Appoints Mario Saltarelli as Non-Executive Director of the Board of Directors

GUILFORD, Conn.–(Business Wire)– Bioasis Technologies, Inc . (OTCQB:BIOAF; TSX.V:BTI), ), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the delivery of therapeutics across the...

Bioasis Announces Closing of Previously Disclosed Private Placement

Tailwinds' Take: Obviously, this cash was needed and will not suffice them for long. We would like to see just how much director and...

Bottom Fishing…

One of my favorite shows to watch on airplanes used to be The Deadliest Catch. This real life drama portrays a group of Alaskan king...

Bioasis Announces Private Placement

Tailwinds' Take: The Company needed this cash infusion rather desperately. I believe that management participated in the transaction. The technology is solid, but they...

Bioasis Appoints Dr. Deborah Rathjen as President & Chief Executive Officer

Tailwinds' Take: while this news comes suddenly and will likely cause some selling in the stock, we view it as constructive. Mark Day has...
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.